Getsios D - Search Results

1

Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK.

Ward A, Caro JJ, Getsios D, Ishak K, O'Brien J, Bullock R; AHEAD Study Group. Ward A, et al. Among authors: getsios d. Int J Geriatr Psychiatry. 2003 Aug;18(8):740-7. doi: 10.1002/gps.919. Int J Geriatr Psychiatry. 2003. PMID: 12891643

2

Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care.

Caro JJ, Getsios D, Migliaccio-Walle K, Raggio G, Ward A; AHEAD Study Group. Caro JJ, et al. Among authors: getsios d. Neurology. 2001 Sep 25;57(6):964-71. doi: 10.1212/wnl.57.6.964. Neurology. 2001. PMID: 11571318

3

Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada.

Getsios D, Caro JJ, Caro G, Ishak K; AHEAD Study Group. Getsios D, et al. Neurology. 2001 Sep 25;57(6):972-8. doi: 10.1212/wnl.57.6.972. Neurology. 2001. PMID: 11571319

4

An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom.

Getsios D, Blume S, Ishak KJ, Maclaine G, Hernández L. Getsios D, et al. Alzheimers Dement. 2012 Jan;8(1):22-30. doi: 10.1016/j.jalz.2010.07.001. Epub 2011 Mar 21. Alzheimers Dement. 2012. PMID: 21420366

5

Sumatriptan: economic evidence for its use in the treatment of migraine, the Canadian comparative economic analysis.

Caro G, Getsios D, Caro JJ, Raggio G, Burrows M, Black L. Caro G, et al. Among authors: getsios d. Cephalalgia. 2001 Feb;21(1):12-9. doi: 10.1046/j.1468-2982.2001.00130.x. Cephalalgia. 2001. PMID: 11298658

6

Treatment of migraine in Canada with naratriptan: a cost-effectiveness analysis.

Caro JJ, Getsios D, Raggio G, Caro G, Black L. Caro JJ, et al. Among authors: getsios d. Headache. 2001 May;41(5):456-64. doi: 10.1046/j.1526-4610.2001.01083.x. Headache. 2001. PMID: 11380643

7

Diabetes in Canada: direct medical costs of major macrovascular complications.

O'Brien JA, Caro I, Getsios D, Caro JJ. O'Brien JA, et al. Among authors: getsios d. Value Health. 2001 May-Jun;4(3):258-65. doi: 10.1046/j.1524-4733.2001.43017.x. Value Health. 2001. PMID: 11705187 Free article. Review.

8

Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.

Caro JJ, Getsios D, Caro I, Klittich WS, O'Brien JA. Caro JJ, et al. Among authors: getsios d. Diabet Med. 2004 Nov;21(11):1229-36. doi: 10.1111/j.1464-5491.2004.01330.x. Diabet Med. 2004. PMID: 15498090

9

The migraine ACE model: evaluating the impact on time lost and medical resource Use.

Caro JJ, Caro G, Getsios D, Raggio G, Burrows M, Black L. Caro JJ, et al. Among authors: getsios d. Headache. 2000 Apr;40(4):282-91. doi: 10.1046/j.1526-4610.2000.00042.x. Headache. 2000. PMID: 10759932

10

Oxybutynin extended release and tolterodine immediate release : a health economic comparison.

Getsios D, Caro JJ, Ishak KJ, El-Hadi W, Payne K, O'connel M, Albrecht D, Feng W, Dubois D. Getsios D, et al. Clin Drug Investig. 2004;24(2):81-8. doi: 10.2165/00044011-200424020-00003. Clin Drug Investig. 2004. PMID: 17516694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters